Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions

Metastatic tumors to the liver account for the majority of hepatic neoplasm s. Improvement in resection has been shown to be beneficial and has remaine d the treatment of choice, carrying a 5-year survival rate of approximately 20 to 30 per cent. In evaluating candidates for surgery, intraoperative as sessment for resectability is a key factor and dictates surgical approach, as well as patient prognosis. Historically, imaging techniques such as CT s can, magnetic resonance imaging, and CT arterial portography (CTAP) have be en used in preoperative evaluation. However, the sensitivities of these dia gnostic tools have been found to be less than optimal. Intraoperative ultra sound (IOUS) has emerged as an important tool in accurately staging metasta tic liver disease with a sensitivity of 98 per cent. From 1994 to 1996, 23 patients have undergone IOUS for evaluation of suspected liver neoplasms in an ongoing prospective study. All patients had colorectal carcinoma. All p atients received preoperative CT scan, and 11 patients with positive CT sca ns had CTAP, Fifteen patients were found to have colorectal metastasis to t he liver. Surgical management in 7 of the 15 patients was modified because of the use of IOUS. Two patients were found to have unresectable disease th us abandoning hepatic resection, two were found to have additional lesions undetected by preoperative evaluation and were resected, and in two patient s margins of resection were changed. One patient was found to have benign h epatic cysts, and no resection was performed. The use of IOUS modified the management of 44 per cent of our patients with liver metastases. IOUS shoul d be routinely used in patients undergoing liver resection for metastatic l iver disease.